Genetics was supposed to revolutionize cancer care. The ability to sequence a tumor sample to identify cancer-driving mutations gave physicians a precision medicine approach to selecting the most ...

The biotech startup Inscripta is attempting to “democratize” CRISPR by offering it to select researchers at no cost, according to Fortune. Here are four things to know about the startup’s business ...

Oct 7, 2020, 10:38am EDT Updated: Oct 7, 2020, 11:06am EDT Spencer A. Brown FILE — CRISPR gene-editing technology inventor Jennifer Doudna of the University of California, Berkeley, accepts the Life ...

Current shareholders were thrown an unexpected curveball that they actually should have been expecting.

Aera Therapeutics, a startup launched by the CRISPR pioneer Feng Zhang last year to solve one of the biggest bottlenecks in genetic medicine, has laid off a quarter of its staff, the company confirmed ...

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

Along Highway 101 north of the San Francisco Airport, a break-out biotech start-up named Mammoth Biosciences co-founded by Nathan Chen's sister Janice in 2018 is fast emerging in the revolutionary ...

The Boston biotech Aera Therapeutics said on Thursday it had raised $193 million. Feng Zhang, Aera's founder and a CRISPR pioneer, spoke with Insider about his vision for the firm. Aera wants to ...

This is today's edition of The Download, our weekday newsletter that provides a daily dose of what's going on in the world of technology. Crypto billionaire Brian Armstrong is ready to invest in ...

Verve Therapeutics, a Cambridge, Mass.-based startup that plans to use gene editing technology to treat heart disease, announced its official launch and $58.5 million in Series A financing on May 7.

CRISPR Therapeutics and Vertex Pharmaceuticals are partners in one particular program, and they recently won approval for the gene-editing treatment Casgevy. Beyond Casgevy, Vertex has a ...

St. Georges Technical High School students using CRISPR in a Box. On Friday, the US Food and Drug Administration approved a sickle cell disease drug called Casgevy, co-developed by Vertex ...